Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells

Journal of Laboratory and Clinical Medicine

Volumn 142, Issue 3, 2003, Pages 178-186

  Baek, Su Mi ^a   Kwon, Chae Hwa ^a   Kim, Jae Ho ^a   Woo, Jae Suk ^a   Jung, Jin Sup ^a   Kim, Yong Keun ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 3; CATALASE; CISPLATIN; CYTOCHROME C; DEFEROXAMINE; DIMETHYLTHIOUREA; HYDROGEN PEROXIDE; HYDROXYL RADICAL; PYRUVIC ACID; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE; THIOUREA; TIRON; TROLOX C;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME RELEASE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MALE; NEPHROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; RABBIT; SIGNAL TRANSDUCTION;

EID: 0141921798     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(03)00111-2     Document Type: Article

References (44)

1. Inselmann G, Blomer A, Kottny W, Nellessen U, Hanel H, Heidemann HT. Modification of cisplatin-induced renal p-aminohippurate uptake alteration and lipid peroxidation by thiols, Ginkgo biloba extract, deferoxamine and torbafylline. Nephron 1995;70:425-9.
2. Garnick MB, Mayer RJ, Abelson HT. Acute renal failure associated with cancer treatment. In: Brenner BM, Lazarus JM, Brenner BM, Lazarus JM, eds. Acute renal failure. New York, NY: Churchill Livingtone; 1988:621-57.
3. Madias NE, Harrington JT. Platinum nephrotoxicity. Am J Med 1978;65:307-14.
4. Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW. Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. J Pharmacol Exp Ther 1980;213:551-6.
5. Safirstein R, Winston J, Moel D, Dikman S, Guttenplan J. Cisplatin nephrotoxicity: insights into mechanism. Int J Androl 1987;10:325-46.
6. Cohen JJ, Duke RC, Fadok VA, Sellins KS. Apoptosis and programmed cell death in immunity. Annu Rev Immunol 1992; 10:267-93.
7. Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 1992;11:95-103.
8. Blachley JD, Hill JB. Renal and electrolyte disturbances associated with cisplatin. Ann Intern Med 1981;95:628-32.
9. Kroning R, Katz D, Lichtenstein AK, Nagami GT. Differential effects of cisplatin in proximal and distal renal tubule epithelial cell lines. Br J Cancer 1999;79:293-9.
10. Lieberthal W, Triaca V, Levine J. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am J Physiol 1996;270:F700-8.
11. 1. Implication of the functions of apical membranes. Biochem Pharmacol 2000;59:195-201.
12. Takeda M, Fukuoka K, Endou H. Cisplatin-induced apoptosis in mouse proximal tubular cell line. Contrib Nephrol 1996;118: 24-8.
13. Zhou H, Miyaji T, Kato A, Fujigaki Y, Sano K, Hishida A. Attenuation of cisplatin-induced acute renal failure is associated with less apoptotic cell death. J Lab Clin Med 1999;134:649-58.
14. Lieberthal W, Levine JS. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am J Physiol 1996;271:F477-88.
15. Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev 1999;31:971-97.
16. 2+ in cisplatin-induced cell injury in rabbit renal cortical slices. Toxicol Appl Pharmacol 1997;146:261-9.
17. Lee RH, Song JM, Park MY, Kang SK, Kim YK, Jung JS. Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells. Biochem Pharmacol 2001;62: 1013-23.
18. Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV. In vitro and in vivo evidence suggesting a role for iron in cisplatin- induced nephrotoxicity. Kidney Int 1998;53:394-401.
19. Matsushima H, Yonemura K, Ohishi K, Hishida A. The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J Lab Clin Med 1998;131:518-26.
20. Ikeda K, Kajiwara K, Tanabe E, Tokumaru S, Kishida E, Masuzawa Y, et al. Involvement of hydrogen peroxide and hydroxyl radical in chemically induced apoptosis of HL-60 cells. Biochem Pharmacol 1999;57:1361-5.
21. Wang X, Martindale JL, Holbrook NJ. Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 2000;275: 39435-3.
22. 1 cells via activation of mitochondrial pathways. J Am Soc Nephrol 2002;13:858-65.
23. 2 toxicity between intact renal tubules and cultured proximal tubular cells. Biochem Pharmacol 1998;56:489-95.
24. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-6.
25. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997;275:1129-32.
26. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999;68:383-424.
27. Sugihara K, Nakano S, Koda M, Tanaka K, Fukuishi N, Gemba M. Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn J Pharmacol 1987;43:247-52.
28. Hannemann J, Baumann K. Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: different effects of antioxidants and radical scavengers. Toxicology 1988; 51:119-32.
29. Masuda H, Tanaka T, Takahama U. Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun 1994;203:1175-80.
30. 2 production in cisplatin-induced nephrotoxicity. Biochem Biophys Res Commun 1998;242:310-2.
31. McGinness JE, Proctor PH, Demopoulos HB, Hokanson JA, Kirkpatrick DS. Amelioration of cis-platinum nephrotoxicity by orgotein (superoxide dismutase). Physiol Chem Phys 1978;10: 267-77.
32. Davis CA, Nick HS, Agarwal A. Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol 2001; 12:2683-690.
33. Nishikawa M, Nagatomi H, Chang BJ, Sato E, Inoue M. Targeting superoxide dismutase to renal proximal tubule cells inhibits mitochondrial injury and renal dysfunction inuduced by cisplatin. Arch Biochem Biophys 2001;387:78-84.
34. Halliwell B. Antioxidant characterization. Methodology and mechanism. Biochem Pharmacol 1995;49:1341-8.
35. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 1996; 85:803-15.
36. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305-8.
37. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. Embo J 1995;14:5579-88.
38. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281:1309-12.
39. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997;90:405-13.
40. Kaushal GP, Kaushal V, Hong X, Shah SV. Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells. Kidney Int 2001;60:1726-36.
41. Cummings BS. Schnellmann RG. Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. J Pharmacol Exp Ther 2002;302:8-17.
42. + transport, and cisplatin-induced apoptosis in renal cells. J Biol Chem 2002;277:43377-88.
43. Choie DD, Longnecker DS, del Campo AA. Acute and chronic cisplatin nephropathy in rats. Lab Invest 1981;44:397-402.
44. Jeong JC, Hwang WM, Yoon CH, Kim YK. Salviae radix extract prevents cisplatin-induced acute renal failure in rabbits. Nephron 2001;88:241-6.